Phase ? Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Nasopharyngeal Carcinoma
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Cancer Center of Guangzhou Medical University The Affiliated Hospital of Guizhou Medical University, Guizhou Cancer Hospital The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan Cancer Hospital Masking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 65 years
- Gender
- Both males and females
Description
This phase ? trial is studying how well radiation therapy and chemotherapy work in treating patients with newly diagnosed N2-3 nasopharyngeal cancer. Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as cisplatin and fluorouracil or cisplatin and gemcita...
This phase ? trial is studying how well radiation therapy and chemotherapy work in treating patients with newly diagnosed N2-3 nasopharyngeal cancer. Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as cisplatin and fluorouracil or cisplatin and gemcitabine, work in different ways (concurrent chemoradiotherapy followed by different adjuvant chemotherapy) to stop the growth of tumor cells.
Tracking Information
- NCT #
- NCT03321539
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Hai-Qiang Mai, MD,PhD Sun Yat-sen University
Get Well Soon